HMOX1 and renal cell carcinoma: The association of aberrant HO-1 expression with tumor growth and resistance to therapy has been shown in other types of malignancies, such as human renal cell carcinoma [70], prostate [71] and pancreatic [10] cancers, lymphosarcoma [72], melanoma, and hepatoma [11].